118 related articles for article (PubMed ID: 7350553)
1. Plasma prolactin levels in women at postmenopausal age with a family history of breast cancer or a prescription for antihypertensive Rauwolfia treatment.
de Waard F; Kwa HG; Poortman J
Oncology; 1980; 37(1):33-6. PubMed ID: 7350553
[TBL] [Abstract][Full Text] [Related]
2. Reproductive factors and family history of breast cancer in relation to plasma prolactin levels in premenopausal and postmenopausal women.
Eliassen AH; Tworoger SS; Hankinson SE
Int J Cancer; 2007 Apr; 120(7):1536-41. PubMed ID: 17211859
[TBL] [Abstract][Full Text] [Related]
3. Risk of breast cancer in relation to the use of rauwolfia alkaloids.
Shapiro S; Parsells JL; Rosenberg L; Kaufman DW; Stolley PD; Schottenfeld D
Eur J Clin Pharmacol; 1984; 26(2):143-6. PubMed ID: 6723752
[TBL] [Abstract][Full Text] [Related]
4. Rauwolfia and breast cancer: no relation found in long term users age fifty and over.
Friedman GD
J Chronic Dis; 1983; 36(5):367-70. PubMed ID: 6853662
[TBL] [Abstract][Full Text] [Related]
5. Rauwolfia derivatives and breast cancer. A case/control study in Olmsted County, Minnesota.
O'Fallon WM; Labarthe DR; Kurland LT
Lancet; 1975 Aug; 2(7929):292-6. PubMed ID: 50507
[TBL] [Abstract][Full Text] [Related]
6. Rauwolfia derivatives and breast cancer in hypertensive women.
Armstrong B; Skegg D; White G; Doll R
Lancet; 1976 Jul; 2(7975):8-12. PubMed ID: 59126
[TBL] [Abstract][Full Text] [Related]
7. [Opinion on rauwolfia therapy].
Z Allgemeinmed; 1974 Nov; 50(31):1412. PubMed ID: 4464668
[No Abstract] [Full Text] [Related]
8. Plasma prolactin levels in patients with breast cancer.
Rose DP; Pruitt BT
Cancer; 1981 Dec; 48(12):2687-91. PubMed ID: 7306924
[TBL] [Abstract][Full Text] [Related]
9. Relationship of blood prolactin levels and the risk of subsequent breast cancer.
Wang DY; De Stavola BL; Bulbrook RD; Allen DS; Kwa HG; Fentiman IS; Hayward JL; Millis RR
Int J Epidemiol; 1992 Apr; 21(2):214-21. PubMed ID: 1428472
[TBL] [Abstract][Full Text] [Related]
10. Neuroleptic-induced prolactin level elevation and breast cancer: an emerging clinical issue.
Schyve PM; Smithline F; Meltzer HY
Arch Gen Psychiatry; 1978 Nov; 35(11):1291-1301. PubMed ID: 30426
[TBL] [Abstract][Full Text] [Related]
11. Letter: Rauwolfia derivatives and breast cancer.
Lancet; 1974 Nov; 2(7892):1315-7. PubMed ID: 4139545
[No Abstract] [Full Text] [Related]
12. [Rauwolfia preparations and breast cancer].
Levshin VF
Sov Med; 1977 Sep; (9):145-7. PubMed ID: 929290
[No Abstract] [Full Text] [Related]
13. The permanent effect of reproductive events on blood prolactin levels and its relation to breast cancer risk: a population study of postmenopausal women.
Wang DY; de Stavola BL; Bulbrook RD; Allen DS; Kwa HG; Verstraeten AA; Moore JW; Fentiman IS; Hayward JL; Gravelle IH
Eur J Cancer Clin Oncol; 1988 Jul; 24(7):1225-31. PubMed ID: 3416905
[TBL] [Abstract][Full Text] [Related]
14. Disordered nocturnal prolactin regulation in women with breast cancer.
Malarkey WB; Schroeder LL; Stevens VC; James AG; Lanese RR
Cancer Res; 1977 Dec; 37(12):4650-4. PubMed ID: 922745
[TBL] [Abstract][Full Text] [Related]
15. [Rauwolfia derivatives in relation to breast neoplasms].
Kimlová I; Mottl V
Cas Lek Cesk; 1976 Nov; 115(45):1400-1. PubMed ID: 1000551
[No Abstract] [Full Text] [Related]
16. Reserpine and breast cancer in a retirement community.
Mack TM; Henderson BE; Gerkins VR; Arthur M; Baptista J; Pike MC
N Engl J Med; 1975 Jun; 292(26):1366-71. PubMed ID: 1138164
[TBL] [Abstract][Full Text] [Related]
17. Plasma prolactin and its relationship to risk factors in human breast cancer.
Kwa HG; Cleton F; de Jong-Bakker M; Bulbrook RD; Hayward JL; Wang DY
Int J Cancer; 1976 Apr; 17(4):441-7. PubMed ID: 945228
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of plasma prolactin levels and subsequent risk of breast cancer.
Kwa HG; Cleton F; Wang DY; Bulbrook RD; Bulstrode JC; Hayward JL; Millis RR; Cuzick J
Int J Cancer; 1981 Dec; 28(6):673-6. PubMed ID: 7333701
[TBL] [Abstract][Full Text] [Related]
19. Editorial: Rauwolfia derivatives and cancer.
Lancet; 1974 Sep; 2(7882):701-2. PubMed ID: 4142968
[No Abstract] [Full Text] [Related]
20. Prolactin and breast cancer risk.
Ingram DM; Nottage EM; Roberts AN
Med J Aust; 1990 Oct; 153(8):469-73. PubMed ID: 2215338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
